Perspective Therapeutics, Inc.

CATXAMEX • USD
ThemeHealthcare - Oncology›Radiopharmaceuticals & ADCs
3.14 USD
↘ 0.02 (0.67%)🟢LIVE (AS OF 09:36 AM EDT)
🟢Market: OPEN

Perspective Therapeutics, Inc. (CATX) trades at $3.14 per share. CATX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CATX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 26, 2026.

Open?$3.18
High?$3.23
Low?$3.11
Prev. Close?$3.16
Volume?32.7K
Avg. Volume?1.1M
VWAP?$3.13
Rel. Volume?0.03x
Bid / Ask
Bid?$3.16 × 100
Ask?$3.26 × 1.3K
Spread?$0.10
Midpoint?$3.21
Valuation & Ratios
Market Cap?360.7M
Shares Out?114.2M
Float?94.7M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?1.11
EPS?-$1.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Themes
Healthcare - Oncology›Radiopharmaceuticals & ADCs
Employees
166
Market Cap
360.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.perspectivetherapeutics.com
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
17
Momentum?
50
Short Sent.?
39
Piotroski F-Score?1/9Weak
Altman Z-Score?1.36Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.33%Squeeze Risk
Short Interest?23.0M
Days to Cover?18.2
Free Float94.7M
Avg Daily Volume1.3M
Settlement Date2026-08-14
Financial Health
Current Ratio?6.61Strong
Quick Ratio?6.61Strong
Cash Ratio?1.33Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
95
1.11CHEAP▾
P/S?
Peers
100
S&P
3
881.95HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
767.31HIGH▾
Returns & Efficiency
ROE?
S&P
5
-35.9%WEAK▾
ROA?
S&P
3
-29.7%WEAK▾
Cash Flow & Enterprise
FCF?$-121298000
Enterprise Value?$313.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist